Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,087 | -23,296 | -15,725 | -9,649 | N/A |
| Depreciation Amortization | 181 | 21 | 10 | 9 | N/A |
| Accounts payable and accrued liabilities | 443 | 760 | -759 | -119 | N/A |
| Other Working Capital | 1,004 | 204 | 1 | 97 | N/A |
| Other Operating Activity | 2,223 | 1,190 | 997 | 329 | 0 |
| Operating Cash Flow | $-41,236 | $-21,121 | $-15,476 | $-9,333 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -39,875 | N/A | N/A | N/A | N/A |
| PPE Investments | -565 | -25 | -23 | -8 | N/A |
| Other Investing Activity | -70 | -150 | -30 | 0 | 0 |
| Investing Cash Flow | $-40,510 | $-175 | $-53 | $-8 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 464 | 97,945 | 215 | 4 | N/A |
| Other Financing Activity | 49 | -3,146 | 35,376 | 18,775 | 0 |
| Financing Cash Flow | $513 | $94,799 | $35,591 | $18,779 | $N/A |
| Beginning Cash Position | 105,256 | 31,753 | 11,691 | 2,253 | N/A |
| End Cash Position | 24,023 | 105,256 | 31,753 | 11,691 | N/A |
| Net Cash Flow | $-81,233 | $73,503 | $20,062 | $9,438 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,236 | -21,121 | -15,476 | -9,333 | N/A |
| Capital Expenditure | -565 | -25 | -23 | -8 | N/A |
| Free Cash Flow | -41,801 | -21,146 | -15,499 | -9,341 | 0 |